Mycobacterium boviswith different genotypes and from different hosts induce dissimilar immunopathological lesions in a mouse model of tuberculosis
Swine Diseases
Mice, Inbred BALB C
0303 health sciences
Granuloma
beta-Defensins
Virulence
Reverse Transcriptase Polymerase Chain Reaction
Tumor Necrosis Factor-alpha
Cattle Diseases
Genetic Variation
Nitric Oxide Synthase Type II
Mycobacterium bovis
3. Good health
Colony-Forming Units Assay
Interferon-gamma
Mice
03 medical and health sciences
Models, Animal
Disease Progression
Animals
Cattle
Lung
Tuberculosis, Pulmonary
DOI:
10.1111/j.1365-2249.2009.03923.x
Publication Date:
2009-02-25T10:55:07Z
AUTHORS (8)
ABSTRACT
Summary With the hypothesis that genetic variability of Mycobacterium bovis could influence virulence and immunopathology, five M. strains were selected from an epidemiological study in Argentina on basis their prevalence cattle occurrence other species. We then determined immunopathology evoked by these a well-characterized mouse model progressive pulmonary tuberculosis. The reference strain AN5 was used as control. BALB/c mice infected with this showed 50% survival after 4 months infection, moderate bacillary counts lung. Two weeks inoculation, it induced strong inflammatory response numerous granulomas pneumonia. In contrast, 04-303, isolated wild boar, most lethal its striking feature sudden pneumonia extensive necrosis. Strain 04-302, also boar but different spoligotype, similar pathology to lesser extent. 534, V2 (both cattle) 02-2B (from human) less virulent, permitting higher infection limited tissue damage. human isolates rapid, high stable expression interferon (IFN)-γ inducible nitric oxide synthase (iNOS). more virulent lower IFN-γ, tumour necrosis factor-α iNOS. Interestingly, very low murine beta defensin (mBD-4); whereas, control anti-microbial peptide, peaking at day 120. mBD-4 during early infection. Thus, reported clinical tuberculosis, variable virulence. This can be attributed induction pattern immune response.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (44)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....